Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › atomoxetine

atomoxetine

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of atomoxetine

58 trials tracked of atomoxetine: 32 in phase 3 or 4 and 4 with published results. The most-cited published study has 62 citations.

58Trials tracked
32Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 18 Phase 3 14 Phase 2 18 Phase 1 1 Other / NA 7
  1. Phase 4 Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children Completed · 62 cited
  2. Phase 3 Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism Completed · 45 cited
  3. Phase 4 Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD Completed · 39 cited
  4. Phase 4 Interventions for Children With Attention and Reading Disorders Completed · 4 cited
  5. Phase 4 Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia Completed
  6. Phase 4 Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation Completed
Show 44 more trials
  1. Phase 4 A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) Completed
  2. Phase 4 Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease Completed
  3. Phase 4 Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) Completed
  4. Phase 4 Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes Completed
  5. Phase 4 Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  6. Phase 4 Atomoxetine, Placebo and Parent Management Training in Autism Completed
  7. Phase 4 Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany Completed
  8. Phase 4 Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia Completed
  9. Phase 4 Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children Completed
  10. Phase 4 Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder Completed
  11. Phase 4 Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) Completed
  12. Phase 4 A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine Completed
  13. Phase 4 A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  14. Phase 3 Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD Completed
  15. Phase 3 Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder Completed
  16. Phase 3 Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  17. Phase 3 Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder Completed
  18. Phase 3 A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents Completed
  19. Phase 3 A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder Completed
  20. Phase 3 Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  21. Phase 3 Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  22. Phase 3 Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate Completed
  23. Phase 3 A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  24. Phase 3 Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD) Completed
  25. Phase 3 Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  26. Phase 3 Long-Term, Open Label Atomoxetine Study Completed
  27. Phase 2 Atomoxetine and Huntington's Disease Completed
  28. Phase 2 Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope Completed
  29. Phase 2 Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial Completed
  30. Phase 2 Effects of Atomoxetine in Mild Cognitive Impairment Completed
  31. Phase 2 Crossover Trial of AD036 in Obstructive Sleep Apnea Completed
  32. Phase 2 Post-stroke Neural Plasticity With Atomoxetine Completed
  33. Phase 2 Atomoxetine Treatment for ADHD and Marijuana Dependence Completed
  34. Phase 2 Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) Completed
  35. Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) Completed
  36. Phase 2 A Novel Pharmacological Therapy for Obstructive Sleep Apnea Completed
  37. Phase 2 Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog) Completed
  38. Phase 2 Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD) Completed
  39. Phase 2 Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine Completed
  40. Phase 2 Crossover Trial of AD109 in Obstructive Sleep Apnea Completed
  41. Phase 2 The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder Completed
  42. Phase 2 Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) Completed
  43. Phase 2 Clinical Efficacy of Atomoxetine for Methamphetamine Dependence Completed
  44. Phase 2 Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS) Completed

Showing the 50 most-cited and recently-updated of 58 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Herbal medicines improve ADHD-like behaviors and modulate neurotransmission in preclinical animal models
Psychiatry Meta-analysis
Herbal medicines improve ADHD-like behaviors and modulate neurotransmission in preclinical animal models Herbal medicines show promise for ADHD behaviors in animal models
This systematic review of 25 studies examines the effects of herbal medicines on ADHD-like behaviors in animal models. The authors synthesiz…
Research on herbal mixtures shows they may improve ADHD-like behaviors and boost brain chemicals in animal models, though human safety is no…
Frontiers Jun 18, 2026
Higher ADHD medication doses improve efficacy up to a threshold before benefits plateau
Pediatrics Meta-analysis
Higher ADHD medication doses improve efficacy up to a threshold before benefits plateau Higher ADHD medication doses often stop working or cause more side effects
This network meta-analysis examined oral monotherapy for ADHD in children, adolescents, and adults. Efficacy generally increased with dose u…
A large network analysis of ADHD drugs shows that increasing doses beyond specific limits usually does not improve symptoms and may increase…
Jun 1, 2026